News Updates (13)

FDA Approves Pioneering Microbiome Medicine VOWST, Offering Hope in the Fight Against C. difficile Infections

In a remarkable advancement for the biologics market, the US Food and Drug Administration (FDA) has given its approval to VOWST, a breakthrough orally administered fecal microbiota product. Developed by GenIbet Biopharmaceuticals, a subsidiary of Recipharm, VOWST will be used to prevent recurrent Clostridioides difficile infections (CDI) in adults who have previously undergone antibacterial treatment…

Read More
News Updates (3)

Capitainer Launches Fully Automated Sample Handler for Large-Scale Screening and Diagnostics

Capitainer, a medical technology company, has announced the launch of a fully automated sample handler that allows for large-scale screening and diagnostics using the company’s self-sampling products. The innovative technology reduces the number of manual steps required and decreases the time laboratory staff spends preparing Capitainer samples for analysis. Efficient Large-Scale Studies Made Possible The…

Read More